AMETEK, Inc. (AME) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary indicates robust financial performance with strong sales growth, positive earnings guidance, and strategic acquisitions. The Q&A section supports this with optimistic outlooks for growth across various segments and successful integration of acquisitions. Despite some vague responses, the overall sentiment is positive, driven by strong organic growth initiatives, a solid M&A pipeline, and improved margins. The company's strategic focus on high-value manufacturing and automation, along with a positive outlook for China and defense sectors, further supports a positive stock price movement.
Key Financial Performance
Sales Fourth quarter sales were a record $2 billion, up 13% from the same period in 2024. Organic sales were up 5%. Acquisitions added 7 points in the quarter and foreign currency was a 1-point tailwind.
Orders Overall orders were up 18% to a record $2 billion and organic orders up 7% versus the prior year, leading to a record backlog of $3.58 billion.
Operating Income Operating income was a record $523 million, a 12% increase over the fourth quarter of 2024. Operating margins were 26.2% in the quarter. Core margins were 27.6%, up 100 basis points.
EBITDA EBITDA in the quarter was a record $618 million, up 10% versus the prior year and EBITDA margins a strong 30.9%.
Free Cash Flow Free cash flow was a record $527 million in the quarter, up 6% versus last year's fourth quarter and free cash flow to net income conversion of 132%.
Diluted Earnings Per Share Diluted earnings per share were a record $2.01, up 7% versus the fourth quarter of 2024. Adjusting for an abnormally low tax rate in last year's fourth quarter, diluted earnings per share would have increased 11%.
Electronic Instruments Group (EIG) Sales EIG sales were $1.37 billion, up 13% from last year's fourth quarter. Organic sales were up 2%. Acquisitions added 10 points. Foreign currency was a 1 point tailwind.
Electronic Instruments Group (EIG) Operating Income EIG's fourth quarter operating income was a record $413.7 million, up 7% versus the prior year. Core operating margins were 32.3%, up 50 basis points from the prior year.
Electromechanical Group (EMG) Sales EMG's fourth quarter sales were $629 million, up 15% versus the prior year. Organic sales were up an impressive 14% and foreign currency was a 1 point tailwind.
Electromechanical Group (EMG) Operating Income EMG's operating income in the fourth quarter was $142.5 million, up a sizable 28% compared to the prior year period, while EMG's fourth quarter operating margins were 22.7%, up 240 basis points versus the fourth quarter of 2024.
Full Year Sales Overall sales for the year were $7.4 billion, up 7% from 2024.
Full Year Operating Income Operating income for 2025 was $1.94 billion, up 7% and operating margins were 26.2%, up 10 basis points from the prior year period, while core margins were up a very strong 80 basis points.
Full Year EBITDA EBITDA for the year was $2.33 billion, up 7%, with EBITDA margins of very strong 31.5%.
Full Year Diluted Earnings Per Share Full year 2025 earnings were $7.43 per diluted share, up 9% versus the prior year.
Full Year Free Cash Flow Free cash flow for 2025 was $1.7 billion, with full year free cash flow conversion also very strong at 113% of net income.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Vitality Index: Sales of new products introduced over the last 3 years reached 30%, reflecting strong innovation and product development.
SPECTROMAXx and xSORT: New product family of elemental analysis instruments introduced, broadening technology and market reach with high demand due to rising commodity prices.
LKC Technologies Acquisition: Acquisition broadens MedTech exposure and creates a broader ophthalmic portfolio, enabling diagnosis and management of eye conditions.
European Defense Market: Growing demand for defense products, with AMETEK businesses providing advanced solutions for European air defense systems, aircraft, and UAV platforms.
Record Financial Performance: Achieved record sales ($2 billion in Q4), orders, operating income, EBITDA, and free cash flow ($527 million in Q4).
Operational Margins: Core operating margins reached 27.6% in Q4, with EBITDA margins at 30.9%.
Acquisition Strategy: Completed acquisitions of FARO Technologies and Kern Microtechnik for $1 billion, adding $400 million in annual sales. Strong pipeline for future acquisitions with $5 billion capital available.
Investment in Growth: Invested $90 million in 2025 and planning $100 million in 2026 for R&D, engineering, sales, and digital initiatives to strengthen market position and innovation.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Macroeconomic Uncertainty: The company acknowledges ongoing macroeconomic uncertainty, which could impact industrial markets and overall business performance.
Sluggish Industrial Markets: The company faced sluggish industrial markets in 2025, which could continue to pose challenges to growth and operational performance.
Integration of Acquisitions: The integration of recent acquisitions, such as FARO Technologies and Kern Microtechnik, is ongoing. Challenges in successfully integrating these businesses could impact operational efficiency and financial performance.
Geopolitical Risks: The company highlighted potential economic or geopolitical uncertainties, which could disrupt operations or market conditions.
Tax Rate Increases: The effective tax rate is expected to increase in 2026, which could impact net income and overall profitability.
Capital Expenditure Growth: Capital expenditures are expected to rise in 2026, which could strain financial resources if not managed effectively.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
2026 Sales Growth: Overall sales are expected to increase mid- to high single digits on a percentage basis, with organic sales projected to grow low to mid-single digits compared to the prior year.
2026 Earnings Per Share (EPS): Diluted EPS is anticipated to range between $7.87 and $8.07, representing a 6% to 9% increase compared to 2025.
Q1 2026 Sales and EPS: Sales are expected to grow approximately 10% year-over-year, with adjusted EPS projected to be between $1.85 and $1.90, reflecting a 6% to 9% increase.
Capital Expenditures for 2026: Projected to be approximately $160 million, or about 2% of sales.
Free Cash Flow Conversion for 2026: Expected to range between 110% and 115% of net income.
Tax Rate for 2026: Anticipated to be between 18.5% and 19.5%.
Depreciation and Amortization for 2026: Expected to be approximately $430 million, including $210 million in after-tax acquisition-related intangible amortization.
Acquisition Strategy: AMETEK plans to deploy over $5 billion in capital for acquisitions while maintaining an investment-grade credit rating. The company has a strong pipeline of high-quality acquisition candidates.
Incremental Investments in 2026: An additional $100 million will be invested in research, development, engineering, sales, marketing, and digital initiatives to support growth.
Market Trends and Opportunities: Growing demand is expected in European defense markets and for new products like SPECTROMAXx and xSORT, driven by rising commodity prices and increased defense spending.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Dividend Program: The company has the flexibility to pay a consistently increasing dividend as part of its capital deployment strategy.
Share Repurchase Program: In 2025, the company spent approximately $443 million on share repurchases, including $285 million in the fourth quarter. This is part of their strategy to opportunistically repurchase shares while maintaining financial flexibility.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you provide details on the performance of the medical portfolio, including Paragon and Rauland, and the medium- to long-term outlook?
A:The medical portfolio, which constitutes 21% of the business, performed well. Paragon and Rauland drove results, with low double-digit growth in Q4 and high single-digit growth for the full year 2025. For 2026, the initial guidance is mid-single-digit growth due to challenging comparisons but still healthy performance.
Q:What is the outlook for strategic price capture after dealing with inflation and tariffs?
A:In Q4 2025, there was a positive price/cost spread, with pricing offsetting inflation and tariffs. For 2026, the expectation is to continue offsetting inflation and tariffs with pricing, supported by a refreshed product portfolio and mission-critical products. Price increases are expected to stick, and the company anticipates a positive price/cost spread for the year.
Q:Can you provide an overview of the end markets and regional dynamics?
A:The Process business grew mid-teens in Q4, driven by acquisitions, with low single-digit organic growth. Aerospace and Defense achieved low double-digit growth, with high single-digit organic growth expected in 2026. The Power business grew mid-single digits, driven by grid modernization and data center buildout, with mid-single-digit growth expected in 2026. Automation & Engineered Solutions grew low double digits, with mid-single-digit growth expected in 2026. Geographically, U.S. and international sales were up mid-single digits, Europe grew low single digits, and Asia grew 10%, with China up low double digits.
Q:What is the expected backlog conversion rate for 2026?
A:The backlog conversion rate is expected to be between 30% and 50%, consistent with historical trends. The company is optimistic about order pipelines, with strong orders in December and a good start to the year.
Q:What are the expectations for the EIG segment in 2026?
A:EIG turned positive in Q4 2025 with low single-digit organic growth. For 2026, overall sales are expected to grow mid- to high single digits, with low to mid-single-digit organic growth.
Q:Was there anything unusual driving the 15% growth in EMG sales in Q4 2025?
A:No, the growth was broad-based, with every division within EMG achieving double-digit growth. The company expects tougher comparisons in 2026 but remains confident in EMG's performance.
Q:Are there signs of prebuy or prebuild in channels due to pricing dynamics?
A:No, the market appears more normalized in early 2026 compared to 2025, with no significant prebuy or prebuild activity observed.
Q:What are the pricing expectations for 2026?
A:The company expects to offset inflation and tariffs with pricing, similar to the performance in Q4 2025, where pricing offset inflation and tariffs by about 50 basis points.
Q:What is the progress and outlook for the FARO acquisition?
A:FARO, acquired for 2.7x, is expected to double EBITDA margins from mid-teens to 30% and achieve a 10% return on invested capital by year 3. The integration is progressing well, with restructuring and organizational changes underway. The company is confident in achieving the planned synergies.
Q:What is the outlook for short-cycle recovery and customer conversations?
A:Momentum is building, with a strong pipeline of opportunities and positive segments like Power and Process. The company is cautiously optimistic about a substantive recovery but remains prudent in its guidance.
Q:What is the M&A pipeline outlook for 2026?
A:The M&A pipeline is strong, with a mix of normal quality and larger deals. The company has the capacity to spend $5 billion while maintaining its investment-grade credit rating. M&A is expected to differentiate performance over the next few years.
Q:What is the outlook for China in 2026?
A:China grew low double digits in Q4 2025, driven by Process, Power, and Automation businesses. The company remains conservative but optimistic about continued growth in 2026, supported by strong positions in high-value manufacturing and automation.
Q:How does the current M&A pipeline compare to historical trends?
A:The current pipeline includes a good mix of normal quality and larger deals, with more larger deals than usual. The company remains disciplined and optimistic about executing high-quality acquisitions.
Q:What is the expected margin trajectory for 2026?
A:Margins are expected to expand by 30 basis points in 2026, with 35% incremental margins. Q1 margins may face headwinds due to acquisitions like FARO but are expected to improve throughout the year.
Q:What is the synergy progress for FARO and Paragon?
A:Paragon has achieved EBITDA margins in line with AMETEK and has room for further improvement over the next 12-18 months. FARO is in the early stages of integration, with significant restructuring completed. It is expected to reach 30% EBITDA margins within a couple of years.
Q:What are the expectations for Process business growth in 2026?
A:The Process business grew low single digits in Q4 2025 and is expected to grow low single digits for the full year 2026. Positive segments include semiconductors, instrumentation for metals, and Rauland, while oil and gas and research are less positive.
Q:What is the vitality index and its impact on organic growth?
A:The vitality index is at 30%, driven by strong engineering capabilities and product development. This supports confidence in organic growth and market positioning.
Q:What is the outlook for the defense business?
A:The defense business, comprising about 18% of sales, is well-positioned with strong product lines and opportunities in Europe. The company is open to acquisitions in the defense sector but is confident in its current capabilities.
Q:What are the expectations for research-related businesses in 2026?
A:Research-related businesses are expected to grow in 2026, supported by nuclear research, materials research, and improved pricing dynamics following tariff adjustments.
Q:Review of Unclear Management Responses
A:Management avoided providing specific pricing targets for 2026, stating only that they expect to offset inflation and tariffs. Additionally, they did not disclose terms for a new technology acquisition, citing confidentiality agreements. The response to the question about the M&A pipeline's strength compared to historical trends was vague, emphasizing general optimism without specific details.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Acquisitions point
Core basis
FARO Technologies
LKC Technologies
SPECTRO product
VP Investor
acquisition FARO
acquisition LKC
acquisition cash
analysis
business solution
capital acquisition
core
defense business
deployment acquisition
eye
family
finish
flexibility capital
flow income
flow record
generation
income conversion
income share
niche market
point tailwind
product portfolio
provider
rate tax
record backlog
record cash
record order
result record
result sale
sale income
share cash
share repurchase
track record
work business
AME Transcript
AMETEK, Inc. (AME) Q4 2025 Earnings Call Transcript
Positive2-3
The earnings call summary indicates robust financial performance with strong sales growth, positive earnings guidance, and strategic acquisitions. The Q&A section supports this with optimistic outlooks for growth across various segments and successful integration of acquisitions. Despite some vague responses, the overall sentiment is positive, driven by strong organic growth initiatives, a solid M&A pipeline, and improved margins. The company's strategic focus on high-value manufacturing and automation, along with a positive outlook for China and defense sectors, further supports a positive stock price movement.
AMETEK, Inc. (AME) Q3 2025 Earnings Call Transcript
Positive10-30
The earnings call summary and Q&A indicate strong financial performance, with positive growth in Europe and solid sales and orders. The FARO acquisition is progressing well, and the company has a strong M&A pipeline. Despite some unclear management responses, the overall sentiment is positive, supported by optimistic guidance and strong margins. The business is well-positioned for growth, with record EMG margins and a solid outlook for Aerospace & Defense. These factors suggest a positive stock price movement over the next two weeks.
AMETEK, Inc. (AME) Q2 2025 Earnings Call Transcript
Positive7-31
The earnings call summary indicates strong performance in Aerospace and Defense, as well as growth in Automation and Engineered Solutions. The integration of FARO and Paragon's performance are positive indicators. The M&A pipeline is robust, and the company has mitigated tariff impacts. Although some uncertainties exist, such as in the research and academia market, the overall sentiment is positive, supported by strategic investments, new product introductions, and a significant share repurchase authorization. The positive aspects outweigh the negatives, suggesting a positive stock price movement.
AMETEK, Inc. (NYSE:AME) Q1 2025 Earnings Call Transcript
Positive5-2
The earnings call highlights several positive aspects: a strong financial performance with increased EPS, operating margins, and EBITDA; a promising outlook with increased orders and growth in the medical and aerospace sectors; and a shareholder-friendly approach with an increased dividend and significant share repurchase authorization. Despite some uncertainties, such as tariff impacts and project delays, the overall sentiment is positive, supported by strong financial metrics and strategic growth initiatives, suggesting a likely stock price increase in the near term.
AME Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
